DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+33.56%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$5.42B
AUM Growth
+$5.42B
(+19%)
Cap. Flow
+$277M
Cap. Flow
% of AUM
5.11%
Top 10 Holdings %
Top 10 Hldgs %
57.84%
Holding
242
New
154
Increased
21
Reduced
12
Closed
14
Top Buys
| 1 |
Oscar Health
OSCR
|
$103M |
| 2 |
Baxter International
BAX
|
$52.5M |
| 3 |
Revolution Medicines
RVMD
|
$38.4M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
$36.7M |
| 5 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
$34.4M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$41.2M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$38.5M |
| 3 |
Merus
MRUS
|
$23.6M |
| 4 |
Owens & Minor
OMI
|
$23.2M |
| 5 |
Roivant Sciences
ROIV
|
$18.7M |
Sector Composition
| 1 | Healthcare | 78.16% |
| 2 | Technology | 0.1% |
| 3 | Industrials | 0.09% |
| 4 | Consumer Discretionary | 0.08% |
| 5 | Consumer Staples | 0.07% |